New point-of-care ultrasound technology cleared, launched
Click Here to Manage Email Alerts
Philips announced the FDA clearance and launch of a new version of its point-of-care hand-held ultrasound for CV and other applications.
According to a press release from the company, the hand-held ultrasound system (Lumify) now has Pulse Wave Doppler to help clinicians quantify blood flow in cardiology, vascular, abdominal, urology, obstetrics and gynecology applications.
The new technology can better help clinicians differentiate between arterial and venous blood flow and quantify hemodynamic function, which could improve clinical decision-making, the company stated in the release.
The system also has B-line software and intelligent algorithms to enhance assessments of the heart and the lungs, which is helpful in treating patients with severe COVID-19, according to the release.
“With the addition of Pulse Wave Doppler and enhanced obstetrics measurements, we have increased the number of markers on which diagnoses can be made, to deliver high-quality imaging and enhance the evaluation and effectiveness of treatment in real time,” Matthijs Groot Wassink, general manager of point-of-care ultrasound at Philips, said in the release.
Collapse
Click Here to Manage Email Alerts